Change search
ReferencesLink to record
Permanent link

Direct link
Reviewing dengue: still a neglected tropical disease?
Institute of Public Health, University of Heidelberg, Heidelberg, Germany.
Institute of Public Health, University of Heidelberg, Heidelberg, Germany ; Steinhardt School of Culture, Education and Human Development and Global Institute of Public Health, New York University, New York, New York, United States of America.
Umeå University, Faculty of Medicine, Department of Public Health and Clinical Medicine, Epidemiology and Global Health. Institute of Public Health, University of Heidelberg, Heidelberg, Germany ; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore.
2015 (English)In: PLoS Neglected Tropical Diseases, ISSN 1935-2727, E-ISSN 1935-2735, Vol. 9, no 4, e0003632Article, review/survey (Refereed) Published
Abstract [en]

Dengue is currently listed as a "neglected tropical disease" (NTD). But is dengue still an NTD or not? Classifying dengue as an NTD may carry advantages, but is it justified? This review considers the criteria for the definition of an NTD, the current diverse lists of NTDs by different stakeholders, and the commonalities and differences of dengue with other NTDs. We also review the current research gaps and research activities and the adequacy of funding for dengue research and development (R&D) (2003-2013). NTD definitions have been developed to a higher precision since the early 2000s, with the following main features: NTDs are characterised as a) poverty related, b) endemic to the tropics and subtropics, c) lacking public health attention, d) having poor research funding and shortcomings in R&D, e) usually associated with high morbidity but low mortality, and f) often having no specific treatment available. Dengue meets most of these criteria, but not all. Although dengue predominantly affects resource-limited countries, it does not necessarily only target the poor and marginalised in those countries. Dengue increasingly attracts public health attention, and in some affected countries it is now a high profile disease. Research funding for dengue has increased exponentially in the past two decades, in particular in the area of dengue vaccine development. However, despite advances in dengue research, dengue epidemics are increasing in frequency and magnitude, and dengue is expanding to new areas. Specific treatment and a highly effective vaccine remain elusive. Major research gaps exist in the area of integrated surveillance and vector control. Hence, although dengue differs from many of the NTDs, it still meets important criteria commonly used for NTDs. The current need for increased R& D spending, shared by dengue and other NTDs, is perhaps the key reason why dengue should continue to be considered an NTD.

Place, publisher, year, edition, pages
Public library science , 2015. Vol. 9, no 4, e0003632
National Category
Infectious Medicine
URN: urn:nbn:se:umu:diva-105270DOI: 10.1371/journal.pntd.0003632ISI: 000354972200019PubMedID: 25928673OAI: diva2:824565
Available from: 2015-06-22 Created: 2015-06-22 Last updated: 2015-06-22Bibliographically approved

Open Access in DiVA

fulltext(574 kB)98 downloads
File information
File name FULLTEXT01.pdfFile size 574 kBChecksum SHA-512
Type fulltextMimetype application/pdf

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Wilder-Smith, Annelies
By organisation
Epidemiology and Global Health
In the same journal
PLoS Neglected Tropical Diseases
Infectious Medicine

Search outside of DiVA

GoogleGoogle Scholar
Total: 98 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 52 hits
ReferencesLink to record
Permanent link

Direct link